BP001411-PRO-783: Recombinant Human Growth Arrest and DNA Damage-Inducible Protein GADD45 ? (GADD45A)
Source: E. coli-derived.
Purity: > 85.0% by SDS-PAGE.BP000565-ENZ-399: Recombinant E. coli G6PD (Glucose-6-phosphate 1-dehydrogenase)
Source: E. coli-derived.
Specific activity is 8-10 units/ml obtained by measuring the increase of NADPH in absorbance at 340 nm resulting from the reduction of NAD or NADP. One unit oxidizes 1.0 umole D-glucose-6-phosphate to 6-phospho-D-gluconate per min in the presence of beta-NADP at pH 7.4 at 25C.
Purity > 90%, by SDS-PAGE.BP000565-ENZ-608: Recombinant Human G6PD (Glucose-6-phosphate 1-dehydrogenase)
Source: Hi-5 cells-derived.
Specific activity is > 7 units/ml obtained by measuring the increase of NADPH in absorbance at 340 nm resulting from the reduction of NAD or NADP. One unit oxidizes 1.0 umole D-glucose-6-phosphate to 6-phospho-D-gluconate per min in the presence of beta-NADP at pH 7.4 at 25C.
Purity > 95%, by SDS-PAGE.BP000175-CYT-018: Recombinant Human Granulocyte colony-stimulating factor (G-CSF) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependent proliferation of murine NFS-60 indicator cells is less than 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 95% by SEC-HPLC.BP000470-PRO-318: Recombinant Human Coagulation Factor-VIII (FVIII) Protein
Source: CHO cells-derived.
The specific activity of recombinant human FVIII Protein was found to be 7428 IU/mg.
Purity: > 97.0% as determined by SDS-PAGE.BP000470-PRO-317: Human Coagulation Factor-VIII (FVIII) Protein
Source: Human Plasma-derived.
The potency per mg of Human Coagulation Factor-VIII was tested and found to be 150 Units/mg.BP001407-ENZ-589: Recombinant E.coli Formamidopyrimidine-DNA Glycosylase (Fpg) Enzyme
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000993-PKA-245: Recombinant Human VEGFR3 Fc Chimera
Source: Insect Cells-derived.
Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human VEGFR-3/FLT-4 at 5 ?/ml can bind recombinant rat VEGF-C in a linear range of 8-500 ng/ml.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000993-PKA-244: Recombinant Human VEGFR3
Source: Insect Cells-derived.
Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human VEGFR-3/FLT-4 at 5 ng/ml can bind recombinant rat VEGF-C in a linear range of 8-500 ng/ml.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000045-CYT-157: Recombinant Rhesus Macaque Flt3 Ligand
Source: E. coli-derived.
The ED50 as calculated by the dose-dependant stimulation of the proliferation of human AML5 cells is less than 1.0 ng/ml, corresponding to a specific activity of 1,000,000 IU/mg.
Purity: > 97.0% as determined by SDS-PAGE.